Abbott Laboratories reports third-quarter 2026 results before the market opens on October 21, 2026. Abbott Laboratories sells medical devices, diagnostic tests, nutrition products, and medicines. Adjusted earnings are $1.42 per share, matching estimates. Revenue is $13.01 billion, slightly above the $12.99 billion estimate. Abbott reports sales growth of 14.5% and comparable sales growth of 7.0%. Comparable sales growth includes Exact Sciences, which Abbott acquired on March 23, 2026. Under standard account ...